Dr reddy's sec filings
WebDR. REDDY'S LABORATORIES LTD. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500034. Telangana, India. ... Dr. Reddy’s Laboratories Limited announces filing of Annual Report on Form 20-F Hyderabad, India, June 16, 2024 For Immediate Release ... accessed by selecting ‘SEC filings’ under ‘Reports and Filings’ section under ‘Investors ... WebJul 1, 2024 · June 30, 2024 11:58 PM Eastern Daylight Time. HYDERABAD, India-- ( BUSINESS WIRE )--Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, …
Dr reddy's sec filings
Did you know?
WebMar 24, 2024 · Assenagon Asset Management S.A. increased its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Get Rating) by 210.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 196,038 shares of the company's stock af WebMar 1, 2024 · Dimensional Fund Advisors LP increased its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Get Rating) by 9.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 836,937 shares of the company's stock
WebDr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives. WebDec 6, 2024 · ...
WebApr 4, 2024 · Latest SEC filings for Dr. Reddy's Laboratories Limited (RDY). Seeking Alpha - Go to Homepage Entering text into the input field will update the search result … WebJan 20, 2024 · Hyderabad, India; January 20, 2024 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as …
WebVarious SEC filing data available including balance sheets, cash flows and more. Central Index Key (CIK) and ticker conversions for looking up companies. Obtain spreadsheets …
WebDr. Reddy’s announces ANDA filing for Olanzapine ODT. Hyderabad, India, March 11 2003: Dr. Reddy’s Laboratories (NYSE: RDY) today announced that the Company had filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for Olanzapine Orally Disintegrating Tablets (ODT), equivalent to 5mg, 10mg, 15mg and … butttt jointWebMar 28, 2024 · Sequoia Financial Advisors LLC lifted its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Get Rating) by 118.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,531 shares of the co butts johnsonWebMar 28, 2024 · Sequoia Financial Advisors LLC lifted its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Get Rating) by 118.5% during the 4th quarter, … butty hutWebApr 5, 2024 · Dr. Reddy's Q1 FY22 Financial Results Hyderabad, India, July 27, 2024: ... out of the arbitration award in favor of Hatchtech towards the Xeglyze product as an adjusting subsequent event for filing IFRS financials with US SEC in Form 20F on June 30, 2024. Commenting on the results, Co-Chairman & MD, G V Prasad said "The financial … buttusWeb2005. 2001. Pre. May. Earnings Release - Q4 FY22. Apr. Dr. Reddy's Laboratories announces the launch of Methylprednisolone Sodium Succinate for Injection, USP in the U.S. Market. Dr. Reddy's Laboratories announces the launch of Methylprednisolone. Dr. Reddy's Laboratories and MediCane Health announce the launch of medical cannabis … buttylifeWebFeb 22, 2024 · securities and exchange commission. washington, d.c. 20549 . form 6-k . report of foreign private issuer pursuant to rule 13a-16 or 15d-16. under the securities … butty van hireWebDr. Reddy’s Q4 & FY20 Financial Results. Dr. Reddy’s Laboratories announces the launch of FXR™ (obeticholic acid) in India. Dr. Reddy's Laboratories announces the launch of Desmopressin Acetate Injection USP, 4 mcg/mL in the U.S. Market. Dr. Reddy's Laboratories received approval for their NDA, ELYXYB™ (celecoxib oral solution) 25 … butty man kick